Role of sulfiredoxin as a peroxiredoxin-2 denitrosylase in human iPSC-derived dopaminergic neurons

Significance S-nitrosylation, addition of an NO group to a cysteine thiol, can regulate protein activity. Aberrant protein S-nitrosylation, however, can disrupt normal enzyme function, as is the case for S-nitrosylated peroxiredoxin (SNO-Prx), which would otherwise catabolize toxic peroxides that occur under neurodegenerative conditions such as Parkinson’s disease. Here, we describe a paradigm of N-phosphorylation–mediated denitrosylation by the enzyme sulfiredoxin that removes NO from Prx. The findings are at the center of redox control of the cell, explaining reactivation by sulfiredoxin of both Prx-SO2H and SNO-Prx and thus describe a master regulator of redox reactions that combats nitrosative and oxidative stress in cells. These results suggest that sulfiredoxin may be an important target for therapeutic intervention in neurodegenerative disorders. Recent studies have pointed to protein S-nitrosylation as a critical regulator of cellular redox homeostasis. For example, S-nitrosylation of peroxiredoxin-2 (Prx2), a peroxidase widely expressed in mammalian neurons, inhibits both enzymatic activity and protective function against oxidative stress. Here, using in vitro and in vivo approaches, we identify a role and reaction mechanism of the reductase sulfiredoxin (Srxn1) as an enzyme that denitrosylates (thus removing -SNO) from Prx2 in an ATP-dependent manner. Accordingly, by decreasing S-nitrosylated Prx2 (SNO-Prx2), overexpression of Srxn1 protects dopaminergic neural cells and human-induced pluripotent stem cell (hiPSC)-derived neurons from NO-induced hypersensitivity to oxidative stress. The pathophysiological relevance of this observation is suggested by our finding that SNO-Prx2 is dramatically increased in murine and human Parkinson’s disease (PD) brains. Our findings therefore suggest that Srxn1 may represent a therapeutic target for neurodegenerative disorders such as PD that involve nitrosative/oxidative stress.

[1]  B. Braeckman,et al.  Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2 , 2014, Proceedings of the National Academy of Sciences.

[2]  A. Holmgren,et al.  Thioredoxin-related protein of 14 kDa is an efficient L-cystine reductase and S-denitrosylase , 2014, Proceedings of the National Academy of Sciences.

[3]  J. Hayes,et al.  The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. , 2014, Trends in biochemical sciences.

[4]  S. Lipton,et al.  Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs. , 2013, Free radical biology & medicine.

[5]  John R. Yates,et al.  Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription , 2013, Cell.

[6]  T. Ziv,et al.  Multilevel Regulation of 2-Cys Peroxiredoxin Reaction Cycle by S-Nitrosylation* , 2013, Journal of Biological Chemistry.

[7]  S. Choi,et al.  Distinct Characteristics of Two 2-Cys Peroxiredoxins of Vibrio vulnificus Suggesting Differential Roles in Detoxifying Oxidative Stress* , 2012, The Journal of Biological Chemistry.

[8]  D. Surmeier,et al.  Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD , 2011, Nature.

[9]  F. Cejudo,et al.  Overoxidation of 2-Cys Peroxiredoxin in Prokaryotes , 2010, The Journal of Biological Chemistry.

[10]  J. Stamler,et al.  Identification of S-nitrosylated targets of thioredoxin using a quantitative proteomic approach. , 2010, Biochemistry.

[11]  Beate Ritz,et al.  Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. , 2009, American journal of epidemiology.

[12]  K. Shokat,et al.  Human Carbonyl Reductase 1 Is an S-Nitrosoglutathione Reductase* , 2008, Journal of Biological Chemistry.

[13]  W. Lowther,et al.  Reduction of Cysteine Sulfinic Acid in Peroxiredoxin by Sulfiredoxin Proceeds Directly through a Sulfinic Phosphoryl Ester Intermediate* , 2008, Journal of Biological Chemistry.

[14]  W. Lowther,et al.  Identification of Intact Protein Thiosulfinate Intermediate in the Reduction of Cysteine Sulfinic Acid in Peroxiredoxin by Human Sulfiredoxin* , 2008, Journal of Biological Chemistry.

[15]  A. van Dorsselaer,et al.  Evidence for the Formation of a Covalent Thiosulfinate Intermediate with Peroxiredoxin in the Catalytic Mechanism of Sulfiredoxin* , 2008, Journal of Biological Chemistry.

[16]  D. Matthews,et al.  Nitric oxide regulation of MMP-9 activation and its relationship to modifications of the cysteine switch. , 2008, Biochemistry.

[17]  W. Lowther,et al.  Structure of the sulphiredoxin–peroxiredoxin complex reveals an essential repair embrace , 2008, Nature.

[18]  S. Lipton,et al.  S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.

[19]  William Stafford Noble,et al.  Semi-supervised learning for peptide identification from shotgun proteomics datasets , 2007, Nature Methods.

[20]  Dominique A. Glauser,et al.  Bmc Molecular Biology Transcriptional Response of Pancreatic Beta Cells to Metabolic Stimulation: Large Scale Identification of Immediate-early and Secondary Response Genes , 2022 .

[21]  S. Ryter,et al.  Thioredoxin catalyzes the denitrosation of low-molecular mass and protein S-nitrosothiols. , 2007, Biochemistry.

[22]  J. Trojanowski,et al.  Pesticide Exposure Exacerbates α-Synucleinopathy in an A53T Transgenic Mouse Model , 2007 .

[23]  M. Mann,et al.  In-gel digestion for mass spectrometric characterization of proteins and proteomes , 2006, Nature Protocols.

[24]  Takashi Uehara,et al.  S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration , 2006, Nature.

[25]  R. Gross,et al.  Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats , 2005, Neurobiology of Disease.

[26]  T. Dawson,et al.  Nitric oxide, S-nitrosylation and neurodegeneration. , 2005, Cellular and molecular biology.

[27]  W. Lowther,et al.  Structural basis for the retroreduction of inactivated peroxiredoxins by human sulfiredoxin. , 2005, Biochemistry.

[28]  S. Rhee,et al.  Reduction of Cysteine Sulfinic Acid by Sulfiredoxin Is Specific to 2-Cys Peroxiredoxins* , 2005, Journal of Biological Chemistry.

[29]  H. E. Marshall,et al.  Protein S-nitrosylation: purview and parameters , 2005, Nature Reviews Molecular Cell Biology.

[30]  S. Rhee,et al.  Characterization of Mammalian Sulfiredoxin and Its Reactivation of Hyperoxidized Peroxiredoxin through Reduction of Cysteine Sulfinic Acid in the Active Site to Cysteine* , 2004, Journal of Biological Chemistry.

[31]  John D. Venable,et al.  MS1, MS2, and SQT-three unified, compact, and easily parsed file formats for the storage of shotgun proteomic spectra and identifications. , 2004, Rapid communications in mass spectrometry : RCM.

[32]  Takashi Uehara,et al.  Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Troncoso,et al.  S-Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function , 2004, Science.

[34]  M. Toledano,et al.  ATP-dependent reduction of cysteine–sulphinic acid by S. cerevisiae sulphiredoxin , 2003, Nature.

[35]  P. Karplus,et al.  Peroxiredoxin Evolution and the Regulation of Hydrogen Peroxide Signaling , 2003, Science.

[36]  Sue Goo Rhee,et al.  Inactivation of Human Peroxiredoxin I during Catalysis as the Result of the Oxidation of the Catalytic Site Cysteine to Cysteine-sulfinic Acid* , 2002, The Journal of Biological Chemistry.

[37]  E. Richfield,et al.  Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. , 2002, Neurotoxicology.

[38]  F. Horling,et al.  The function of the chloroplast 2-cysteine peroxiredoxin in peroxide detoxification and its regulation. , 2002, Journal of experimental botany.

[39]  J. Yates,et al.  DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. , 2002, Journal of proteome research.

[40]  M. Zeng,et al.  A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans , 2001, Nature.

[41]  Paul Tempst,et al.  Protein S-nitrosylation: a physiological signal for neuronal nitric oxide , 2001, Nature Cell Biology.

[42]  J. Stamler,et al.  S-nitrosylation: spectrum and specificity , 2001, Nature Cell Biology.

[43]  E. Richfield,et al.  The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's Disease , 2000, The Journal of Neuroscience.

[44]  S. King,et al.  P-Nitrosophosphate compounds: new N-O heterodienophiles and nitroxyl delivery agents. , 2000, The Journal of organic chemistry.

[45]  E. Richfield,et al.  Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson’s disease? , 2000, Brain Research.

[46]  D. Jensen,et al.  S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme. , 1998, The Biochemical journal.

[47]  J. Jeng,et al.  Environmental risk factors and Parkinson's disease , 1997, Neurology.

[48]  J. Yates,et al.  An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.

[49]  N Vanacore,et al.  Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate). , 1994, Scandinavian journal of work, environment & health.

[50]  S. Rhee,et al.  Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae. , 1993, The Journal of biological chemistry.

[51]  S. Lipton,et al.  Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex , 1992, Neuron.

[52]  J. Trojanowski,et al.  Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model. , 2007, The American journal of pathology.

[53]  Joshua E. Elias,et al.  Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. , 2003, Journal of proteome research.